Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Genomic Health Inc (GHDX) since 2014 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Genomic Health Inc. Table 2 shows the detailed insider transactions. This company's CIK number is 1131324.
Total stock buying since 2014: $2,701,600.
Total stock sales since 2014: $524,742,527.
Total stock option exercises since 2014: $54,237,607.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2019 | 37,643,330 | $0 | 4,255,395 | $302,840,723 | 1,177,273 | $31,943,202 |
| 2018 | 0 | $0 | 2,775,805 | $206,377,815 | 561,292 | $12,545,100 |
| 2017 | 0 | $0 | 218,781 | $6,847,246 | 255,541 | $4,916,282 |
| 2016 | 100,000 | $2,701,600 | 148,242 | $4,293,432 | 181,950 | $3,190,607 |
| 2015 | 0 | $0 | 65,864 | $1,910,548 | 65,864 | $879,494 |
| 2014 | 0 | $0 | 85,321 | $2,472,763 | 85,321 | $762,922 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2019-11 | 37,643,330 | $0 | 0 | $0 | 0 | $0 |
| 2019-10 | 0 | $0 | 50,243 | $3,474,351 | 40,243 | $1,148,140 |
| 2019-09 | 0 | $0 | 82,612 | $5,979,926 | 47,612 | $1,354,033 |
| 2019-08 | 0 | $0 | 740,035 | $54,348,279 | 607,854 | $17,843,618 |
| 2019-07 | 0 | $0 | 66,306 | $3,796,472 | 16,306 | $414,942 |
| 2019-06 | 0 | $0 | 99,295 | $5,156,320 | 95,050 | $2,881,256 |
| 2019-05 | 0 | $0 | 43,668 | $2,527,423 | 15,924 | $369,433 |
| 2019-04 | 0 | $0 | 1,127,065 | $75,997,568 | 18,000 | $394,560 |
| 2019-03 | 0 | $0 | 953,706 | $71,500,150 | 56,200 | $1,469,119 |
| 2019-02 | 0 | $0 | 252,034 | $19,873,329 | 209,862 | $4,141,970 |
| 2019-01 | 0 | $0 | 840,431 | $60,186,905 | 70,222 | $1,926,131 |
| 2018-12 | 0 | $0 | 584,964 | $44,114,935 | 44,250 | $896,991 |
| 2018-11 | 0 | $0 | 1,758,955 | $140,039,966 | 110,576 | $2,742,520 |
| 2018-10 | 0 | $0 | 112,000 | $7,300,311 | 112,000 | $2,815,364 |
| 2018-09 | 0 | $0 | 20,250 | $1,270,622 | 20,250 | $560,845 |
| 2018-08 | 0 | $0 | 91,905 | $4,958,171 | 40,279 | $781,054 |
| 2018-07 | 0 | $0 | 15,500 | $803,442 | 15,500 | $267,114 |
| 2018-06 | 0 | $0 | 108,914 | $5,032,005 | 96,268 | $2,313,613 |
| 2018-05 | 0 | $0 | 16,997 | $631,277 | 15,500 | $267,114 |
| 2018-04 | 0 | $0 | 15,000 | $497,880 | 15,000 | $257,700 |
| 2018-03 | 0 | $0 | 10,000 | $325,635 | 59,500 | $1,088,299 |
| 2018-02 | 0 | $0 | 23,316 | $770,230 | 15,000 | $258,449 |
| 2018-01 | 0 | $0 | 18,004 | $633,341 | 17,169 | $296,037 |
| 2017-12 | 0 | $0 | 51,334 | $1,675,587 | 51,000 | $980,958 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2019-11-08 | Exact Sciences Corp (Other) | Buy | 37,643,330 | .00 | 0 |
| 2019-10-17 | Leber Laura (Chief Communication Officer) | Sale | 13,183 | 70.94 | 935,228 |
| 2019-10-17 | Leber Laura (Chief Communication Officer) | Option Ex | 13,183 | 22.98 | 302,945 |
| 2019-10-08 | Vaughn James J (Chief Commercial Officer) | Sale | 4,500 | 67.75 | 304,875 |
| 2019-10-08 | Vaughn James J (Chief Commercial Officer) | Option Ex | 4,500 | 33.21 | 149,445 |
| 2019-10-08 | Popovits Kimberly J (President and CEO) | Sale | 10,000 | 67.74 | 677,360 |
| 2019-10-07 | Cole G Bradley (CFO) | Sale | 22,560 | 69.01 | 1,556,888 |
| 2019-10-07 | Cole G Bradley (CFO) | Option Ex | 22,560 | 30.84 | 695,750 |
| 2019-09-17 | Shak Steven (Chief Scientific Officer) | Sale | 25,000 | 71.47 | 1,786,700 |
| 2019-09-10 | Cole G Bradley (CFO) | Sale | 18,112 | 71.96 | 1,303,411 |
| 2019-09-10 | Cole G Bradley (CFO) | Option Ex | 18,112 | 28.05 | 508,041 |
| 2019-09-09 | Vaughn James J (Chief Commercial Officer) | Sale | 4,500 | 73.15 | 329,170 |
| 2019-09-09 | Vaughn James J (Chief Commercial Officer) | Option Ex | 4,500 | 32.16 | 144,742 |
| 2019-09-09 | Cole G Bradley (CFO) | Sale | 25,000 | 73.15 | 1,828,825 |
| 2019-09-09 | Cole G Bradley (CFO) | Option Ex | 25,000 | 28.05 | 701,250 |
| 2019-09-09 | Popovits Kimberly J (President and CEO) | Sale | 10,000 | 73.18 | 731,820 |
| 2019-08-19 | Pla Frederic (COO) | Sale | 1,251 | 75.00 | 93,825 |
| 2019-08-19 | Pla Frederic (COO) | Option Ex | 1,251 | 27.48 | 34,377 |
| 2019-08-15 | Radford Jason W. (Chief Legal Officer) | Sale | 2,181 | 74.45 | 162,368 |
| 2019-08-13 | Popovits Kimberly J (President and CEO) | Sale | 50,000 | 74.20 | 3,710,000 |
| 2019-08-13 | Popovits Kimberly J (President and CEO) | Option Ex | 30,000 | 29.34 | 880,200 |
| 2019-08-12 | Cole G Bradley (CFO) | Sale | 240,000 | 73.53 | 17,646,240 |
| 2019-08-12 | Cole G Bradley (CFO) | Option Ex | 240,000 | 29.34 | 7,041,600 |
| 2019-08-12 | Popovits Kimberly J (President and CEO) | Sale | 50,000 | 73.53 | 3,676,400 |
| 2019-08-12 | Popovits Kimberly J (President and CEO) | Option Ex | 50,000 | 29.34 | 1,467,000 |
| 2019-08-09 | Popovits Kimberly J (President and CEO) | Sale | 25,000 | 74.00 | 1,850,025 |
| 2019-08-09 | Popovits Kimberly J (President and CEO) | Option Ex | 25,000 | 29.34 | 733,500 |
| 2019-08-08 | Vaughn James J (Chief Commercial Officer) | Sale | 4,500 | 73.67 | 331,515 |
| 2019-08-08 | Vaughn James J (Chief Commercial Officer) | Option Ex | 4,500 | 31.82 | 143,176 |
| 2019-08-08 | Popovits Kimberly J (President and CEO) | Sale | 25,000 | 73.93 | 1,848,200 |
| 2019-08-08 | Popovits Kimberly J (President and CEO) | Option Ex | 25,000 | 29.34 | 733,500 |
| 2019-08-06 | Shak Steven (Chief Scientific Officer) | Sale | 25,000 | 72.50 | 1,812,474 |
| 2019-08-05 | Mceachron Kim (Chief People Officer) | Sale | 12,103 | 71.53 | 865,727 |
| 2019-08-05 | Mceachron Kim (Chief People Officer) | Option Ex | 12,103 | 29.37 | 355,465 |
| 2019-08-05 | Shak Steven (Chief Scientific Officer) | Sale | 25,000 | 71.54 | 1,788,425 |
| 2019-08-02 | Shak Steven (Chief Scientific Officer) | Sale | 25,000 | 72.43 | 1,810,850 |
| 2019-08-01 | Shak Steven (Chief Scientific Officer) | Sale | 25,000 | 72.97 | 1,824,350 |
| 2019-07-09 | Cole G Bradley (CFO) | Sale | 6,471 | 56.78 | 367,416 |
| 2019-07-09 | Cole G Bradley (CFO) | Option Ex | 6,471 | 17.18 | 111,171 |
| 2019-07-09 | Shak Steven (Chief Scientific Officer) | Sale | 25,000 | 56.66 | 1,416,625 |
| 2019-07-08 | Vaughn James J (Chief Commercial Officer) | Sale | 4,500 | 57.37 | 258,178 |
| 2019-07-08 | Vaughn James J (Chief Commercial Officer) | Option Ex | 4,500 | 31.12 | 140,040 |
| 2019-07-08 | Shak Steven (Chief Scientific Officer) | Sale | 25,000 | 57.36 | 1,434,100 |
| 2019-07-05 | Mceachron Kim (Chief People Officer) | Sale | 5,335 | 60.01 | 320,153 |
| 2019-07-05 | Mceachron Kim (Chief People Officer) | Option Ex | 5,335 | 30.69 | 163,731 |
| 2019-06-14 | Shak Steven (Chief Scientific Officer) | Sale | 10,550 | 51.91 | 547,639 |
| 2019-06-14 | Shak Steven (Chief Scientific Officer) | Option Ex | 10,550 | 31.12 | 328,316 |
| 2019-06-13 | Shak Steven (Chief Scientific Officer) | Sale | 25,000 | 52.18 | 1,304,450 |
| 2019-06-13 | Shak Steven (Chief Scientific Officer) | Option Ex | 25,000 | 31.12 | 778,000 |
| 2019-06-12 | Shak Steven (Chief Scientific Officer) | Sale | 25,000 | 51.34 | 1,283,475 |
| 2019-06-12 | Shak Steven (Chief Scientific Officer) | Option Ex | 25,000 | 30.98 | 774,500 |
| 2019-06-11 | Cole G Bradley (CFO) | Sale | 5,000 | 51.82 | 259,090 |
| 2019-06-11 | Cole G Bradley (CFO) | Option Ex | 5,000 | 17.18 | 85,900 |
| 2019-06-11 | Shak Steven (Chief Scientific Officer) | Sale | 25,000 | 51.80 | 1,295,025 |
| 2019-06-11 | Shak Steven (Chief Scientific Officer) | Option Ex | 25,000 | 30.98 | 774,500 |
| 2019-06-06 | Vaughn James J (Chief Commercial Officer) | Sale | 8,745 | 53.36 | 466,641 |
| 2019-06-06 | Vaughn James J (Chief Commercial Officer) | Option Ex | 4,500 | 31.12 | 140,040 |
| 2019-05-14 | Cole G Bradley (CFO) | Sale | 11,424 | 56.97 | 650,848 |
| 2019-05-14 | Cole G Bradley (CFO) | Option Ex | 11,424 | 20.08 | 229,393 |
| 2019-05-08 | Vaughn James J (Chief Commercial Officer) | Sale | 7,244 | 57.95 | 419,775 |
| 2019-05-08 | Vaughn James J (Chief Commercial Officer) | Option Ex | 4,500 | 31.12 | 140,040 |
| 2019-05-08 | Shak Steven (Chief Scientific Officer) | Sale | 25,000 | 58.27 | 1,456,800 |
| 2019-04-12 | Baker Bros. Investments Ii, L.p. (Director) | Sale | 298,669 | 65.60 | 19,668,646 |
| 2019-04-11 | Baker Bros. Investments Ii, L.p. (Director) | Sale | 202,281 | 67.01 | 13,555,658 |
| 2019-04-10 | Baker Bros. Investments Ii, L.p. (Director) | Sale | 137,688 | 68.91 | 9,464,849 |
| 2019-04-09 | Baker Bros. Investments Ii, L.p. (Director) | Sale | 21,063 | 67.77 | 1,427,502 |
| 2019-04-09 | Cole G Bradley (CFO) | Sale | 15,000 | 67.83 | 1,017,479 |
| 2019-04-09 | Cole G Bradley (CFO) | Option Ex | 15,000 | 20.08 | 301,200 |
| 2019-04-08 | Vaughn James J (Chief Commercial Officer) | Sale | 3,000 | 67.58 | 202,745 |
| 2019-04-08 | Vaughn James J (Chief Commercial Officer) | Option Ex | 3,000 | 31.12 | 93,360 |
| 2019-04-08 | Baker Bros. Investments Ii, L.p. (Director) | Sale | 22,648 | 67.90 | 1,537,731 |
| 2019-04-08 | Popovits Kimberly J (President and CEO) | Sale | 10,000 | 67.53 | 675,260 |
| 2019-04-05 | Baker Bros. Investments Ii, L.p. (Director) | Sale | 77,648 | 68.67 | 5,332,243 |
| 2019-04-04 | Baker Bros. Investments Ii, L.p. (Director) | Sale | 81,053 | 66.64 | 5,401,371 |
| 2019-04-03 | Baker Bros. Investments Ii, L.p. (Director) | Sale | 97,269 | 68.90 | 6,701,736 |
| 2019-04-01 | Shak Steven (Chief Scientific Officer) | Sale | 25,000 | 68.97 | 1,724,299 |
| 2019-03-29 | Shak Steven (Chief Scientific Officer) | Sale | 25,000 | 69.79 | 1,744,700 |
| 2019-03-28 | Shak Steven (Chief Scientific Officer) | Sale | 25,000 | 68.95 | 1,723,750 |
| 2019-03-21 | Baker Bros. Investments Ii, L.p. (Director) | Sale | 56,651 | 74.71 | 4,232,169 |
| 2019-03-19 | Pla Frederic (COO) | Sale | 4,700 | 75.00 | 352,500 |
| 2019-03-19 | Pla Frederic (COO) | Option Ex | 4,700 | 28.82 | 135,454 |
| 2019-03-19 | Baker Bros. Investments Ii, L.p. (Director) | Sale | 155,226 | 74.49 | 11,570,242 |
| 2019-03-18 | Pla Frederic (COO) | Sale | 1,000 | 75.12 | 75,122 |
| 2019-03-18 | Pla Frederic (COO) | Option Ex | 1,000 | 27.48 | 27,480 |
| 2019-03-18 | Baker Bros. Investments Ii, L.p. (Director) | Sale | 109,533 | 74.19 | 8,125,924 |
| 2019-03-15 | Baker Bros. Investments Ii, L.p. (Director) | Sale | 55,347 | 75.25 | 4,164,806 |
| 2019-03-14 | Baker Bros. Investments Ii, L.p. (Director) | Sale | 65,094 | 76.27 | 4,964,459 |
| 2019-03-13 | Baker Bros. Investments Ii, L.p. (Director) | Sale | 80,253 | 75.79 | 6,082,294 |
| 2019-03-12 | Baker Bros. Investments Ii, L.p. (Director) | Sale | 74,180 | 75.63 | 5,610,233 |
| 2019-03-12 | Cole G Bradley (CFO) | Sale | 15,000 | 75.40 | 1,130,940 |
| 2019-03-12 | Cole G Bradley (CFO) | Option Ex | 15,000 | 20.08 | 301,200 |
| 2019-03-11 | Baker Bros. Investments Ii, L.p. (Director) | Sale | 49,035 | 74.56 | 3,655,902 |
| 2019-03-08 | Baker Bros. Investments Ii, L.p. (Director) | Sale | 22,700 | 73.55 | 1,669,516 |
| 2019-03-08 | Popovits Kimberly J (President and CEO) | Sale | 10,000 | 73.44 | 734,449 |
| 2019-03-07 | Vaughn James J (Chief Commercial Officer) | Sale | 3,000 | 73.92 | 221,751 |
| 2019-03-07 | Vaughn James J (Chief Commercial Officer) | Option Ex | 3,000 | 31.12 | 93,360 |
| 2019-03-07 | Baker Bros. Investments Ii, L.p. (Director) | Sale | 2,000 | 73.72 | 147,444 |
| 2019-03-05 | Baker Bros. Investments Ii, L.p. (Director) | Sale | 10,300 | 77.04 | 793,501 |
| 2019-03-04 | Baker Bros. Investments Ii, L.p. (Director) | Sale | 27,811 | 76.49 | 2,127,263 |
| 2019-03-04 | Shak Steven (Chief Scientific Officer) | Sale | 7,500 | 76.23 | 571,740 |
| 2019-03-04 | Shak Steven (Chief Scientific Officer) | Option Ex | 7,500 | 28.05 | 210,375 |
| 2019-03-01 | Baker Bros. Investments Ii, L.p. (Director) | Sale | 79,276 | 77.39 | 6,135,486 |
| 2019-03-01 | Shak Steven (Chief Scientific Officer) | Sale | 25,000 | 77.66 | 1,941,375 |
| 2019-03-01 | Shak Steven (Chief Scientific Officer) | Option Ex | 25,000 | 28.05 | 701,250 |
| 2019-02-28 | Shak Steven (Chief Scientific Officer) | Sale | 25,000 | 76.42 | 1,910,425 |
| 2019-02-28 | Shak Steven (Chief Scientific Officer) | Option Ex | 25,000 | 22.61 | 565,375 |
| 2019-02-27 | Baker Bros. Advisors (gp) Llc (Director) | Sale | 39,109 | 76.43 | 2,989,139 |
| 2019-02-27 | Shak Steven (Chief Scientific Officer) | Sale | 25,000 | 76.91 | 1,922,700 |
| 2019-02-27 | Shak Steven (Chief Scientific Officer) | Option Ex | 25,000 | 17.18 | 429,500 |
| 2019-02-26 | Baker Bros. Advisors (gp) Llc (Director) | Sale | 8,650 | 77.97 | 674,440 |
| 2019-02-26 | Baker Bros. Advisors (gp) Llc (Director) | Option Ex | 16,500 | 17.59 | 290,235 |
| 2019-02-21 | Leber Laura (Chief Communication Officer) | Sale | 5,634 | 83.14 | 468,433 |
| 2019-02-21 | Leber Laura (Chief Communication Officer) | Option Ex | 1,817 | 22.98 | 41,754 |
| 2019-02-21 | Pla Frederic (COO) | Sale | 783 | 86.51 | 67,736 |
| 2019-02-20 | Leber Laura (Chief Communication Officer) | Sale | 18,750 | 83.12 | 1,558,462 |
| 2019-02-20 | Leber Laura (Chief Communication Officer) | Option Ex | 18,750 | 17.18 | 322,125 |
| 2019-02-19 | Vaughn James J (Chief Commercial Officer) | Option Ex | 1,195 | 29.06 | 34,726 |
| 2019-02-19 | Radford Jason W. (Chief Legal Officer) | Sale | 3,508 | 83.38 | 292,507 |
| 2019-02-19 | Pla Frederic (COO) | Sale | 9,700 | 83.24 | 807,428 |
| 2019-02-19 | Pla Frederic (COO) | Option Ex | 5,700 | 28.82 | 164,274 |
| 2019-02-14 | Popovits Kimberly J (President and CEO) | Sale | 47,900 | 81.88 | 3,922,052 |
| 2019-02-14 | Popovits Kimberly J (President and CEO) | Option Ex | 47,900 | 17.18 | 822,922 |
| 2019-02-12 | Cole G Bradley (CFO) | Sale | 15,000 | 80.91 | 1,213,575 |
| 2019-02-12 | Cole G Bradley (CFO) | Option Ex | 15,000 | 20.08 | 301,200 |
| 2019-02-07 | Vaughn James J (Chief Commercial Officer) | Sale | 3,000 | 77.56 | 232,683 |
| 2019-02-07 | Vaughn James J (Chief Commercial Officer) | Option Ex | 3,000 | 31.12 | 93,360 |
| 2019-02-04 | Shak Steven (Chief Scientific Officer) | Sale | 25,000 | 76.61 | 1,915,149 |
| 2019-02-04 | Shak Steven (Chief Scientific Officer) | Option Ex | 25,000 | 20.08 | 501,999 |
| 2019-02-01 | Shak Steven (Chief Scientific Officer) | Sale | 25,000 | 75.94 | 1,898,600 |
| 2019-02-01 | Shak Steven (Chief Scientific Officer) | Option Ex | 25,000 | 22.98 | 574,500 |
| 2019-01-31 | Shak Steven (Chief Scientific Officer) | Sale | 25,000 | 74.78 | 1,869,575 |
| 2019-01-31 | Shak Steven (Chief Scientific Officer) | Option Ex | 25,000 | 29.34 | 733,500 |
| 2019-01-30 | Shak Steven (Chief Scientific Officer) | Sale | 25,000 | 73.49 | 1,837,249 |
| 2019-01-30 | Shak Steven (Chief Scientific Officer) | Option Ex | 25,000 | 29.34 | 733,500 |
| 2019-01-28 | Baker Bros. Advisors (gp) Llc (Director) | Sale | 46,477 | 70.95 | 3,297,636 |
| 2019-01-25 | Baker Bros. Advisors (gp) Llc (Director) | Sale | 91,916 | 72.20 | 6,636,610 |
| 2019-01-24 | Baker Bros. Advisors (gp) Llc (Director) | Sale | 79,403 | 72.02 | 5,718,604 |
| 2019-01-23 | Baker Bros. Advisors (gp) Llc (Director) | Sale | 37,512 | 71.99 | 2,700,338 |
| 2019-01-22 | Radford Jason W. (Chief Legal Officer) | Sale | 2,963 | 71.46 | 211,738 |
| 2019-01-22 | Baker Bros. Investments Ii, L.p. (Director) | Sale | 64,406 | 71.31 | 4,580,672 |
| 2019-01-18 | Baker Bros. Investments Ii, L.p. (Director) | Sale | 177,142 | 72.51 | 12,844,212 |
| 2019-01-17 | Vaughn James J (Chief Commercial Officer) | Option Ex | 2,222 | 29.06 | 64,571 |
| 2019-01-17 | Baker Bros. Investments Ii, L.p. (Director) | Sale | 181,747 | 70.79 | 12,866,051 |
| 2019-01-14 | Baker Bros. Investments Ii, L.p. (Director) | Sale | 600 | 70.07 | 42,043 |
| 2019-01-11 | Baker Bros. Investments Ii, L.p. (Director) | Sale | 28,474 | 70.22 | 1,999,529 |
| 2019-01-10 | Baker Bros. Investments Ii, L.p. (Director) | Sale | 10,185 | 70.28 | 715,781 |
| 2019-01-08 | Vaughn James J (Chief Commercial Officer) | Sale | 3,000 | 66.93 | 200,796 |
| 2019-01-08 | Vaughn James J (Chief Commercial Officer) | Option Ex | 3,000 | 31.12 | 93,360 |
| 2019-01-08 | Cole G Bradley (CFO) | Sale | 15,000 | 66.80 | 1,002,045 |
| 2019-01-08 | Cole G Bradley (CFO) | Option Ex | 15,000 | 20.08 | 301,200 |
Insider trading activities including stock purchases, stock sales, and option exercises of GHDX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Genomic Health Inc (symbol GHDX, CIK number 1131324) see the Securities and Exchange Commission (SEC) website.